Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline
Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline News Provided By Share This Article /EIN News/ -- PALO ALTO, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced the formation of its Scientific Advisory Board (SAB) composed of world leading academics and industry leaders in cancer research and therapeutics. John C. Byrd, M.D., will serve as Chairman of the SAB. “...